ALT
Price
$6.79
Change
-$0.07 (-1.02%)
Updated
Oct 17 closing price
18 days until earnings call
VTGN
Price
$3.06
Change
+$0.04 (+1.32%)
Updated
Oct 17 closing price
Ad is loading...

ALT vs VTGN

Header iconALT vs VTGN Comparison
Open Charts ALT vs VTGNBanner chart's image
Altimmune
Price$6.79
Change-$0.07 (-1.02%)
Volume$1.47M
CapitalizationN/A
VistaGen Therapeutics
Price$3.06
Change+$0.04 (+1.32%)
Volume$324.45K
CapitalizationN/A
View a ticker or compare two or three
ALT vs VTGN Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALT vs. VTGN commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a StrongBuy and VTGN is a Hold.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (ALT: $6.79 vs. VTGN: $3.06)
Brand notoriety: ALT and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 68% vs. VTGN: 244%
Market capitalization -- ALT: $459.83M vs. VTGN: $83.06M
ALT [@Biotechnology] is valued at $459.83M. VTGN’s [@Biotechnology] market capitalization is $83.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALT and VTGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 6 bullish TA indicator(s).

  • ALT’s TA Score: 4 bullish, 5 bearish.
  • VTGN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than ALT.

Price Growth

ALT (@Biotechnology) experienced а +12.79% price change this week, while VTGN (@Biotechnology) price change was +1.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

ALT is expected to report earnings on Mar 27, 2025.

VTGN is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALT($460M) has a higher market cap than VTGN($83.1M). ALT (-39.644) and VTGN (-40.467) have similar YTD gains . VTGN has higher annual earnings (EBITDA): -37.57M vs. ALT (-100.91M). ALT has more cash in the bank: 165M vs. VTGN (108M). ALT has less debt than VTGN: ALT (1.86M) vs VTGN (1.99M). VTGN has higher revenues than ALT: VTGN (971K) vs ALT (409K).
ALTVTGNALT / VTGN
Capitalization460M83.1M554%
EBITDA-100.91M-37.57M269%
Gain YTD-39.644-40.46798%
P/E RatioN/AN/A-
Revenue409K971K42%
Total Cash165M108M153%
Total Debt1.86M1.99M94%
FUNDAMENTALS RATINGS
ALT vs VTGN: Fundamental Ratings
ALT
VTGN
OUTLOOK RATING
1..100
514
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
37
Fair valued
PROFIT vs RISK RATING
1..100
80100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
4282
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (37) in the Biotechnology industry is somewhat better than the same rating for ALT (83) in the Miscellaneous Commercial Services industry. This means that VTGN’s stock grew somewhat faster than ALT’s over the last 12 months.

ALT's Profit vs Risk Rating (80) in the Miscellaneous Commercial Services industry is in the same range as VTGN (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to VTGN’s over the last 12 months.

ALT's SMR Rating (97) in the Miscellaneous Commercial Services industry is in the same range as VTGN (97) in the Biotechnology industry. This means that ALT’s stock grew similarly to VTGN’s over the last 12 months.

ALT's Price Growth Rating (42) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for VTGN (82) in the Biotechnology industry. This means that ALT’s stock grew somewhat faster than VTGN’s over the last 12 months.

ALT's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as VTGN (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTVTGN
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with BEAM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+1.32%
BEAM - VTGN
45%
Loosely correlated
-8.77%
ATAI - VTGN
43%
Loosely correlated
-0.83%
NTLA - VTGN
43%
Loosely correlated
+1.94%
ALT - VTGN
43%
Loosely correlated
-1.02%
INZY - VTGN
43%
Loosely correlated
-3.01%
More